986 studies found for:    "Hodgkin Disease"
Show Display Options
Rank Status Study
21 Recruiting A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: panobinostat;   Drug: lenalidomide
22 Completed Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy
Condition: Hodgkin Disease
Interventions: Drug: Filgrastim SD/01;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: DTIC
23 Unknown  Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide (Revlimid®)
24 Unknown  Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Condition: Hodgkin Disease
Interventions: Drug: Combined chemotherapy (ABVD, BACOPP-D);   Procedure: Radiation therapy
25 Recruiting A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Condition: Hodgkin Disease
Interventions: Drug: brentuximab vedotin;   Drug: dacarbazine
26 Terminated Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Bortezomib;   Drug: Dexamethasone
27 Recruiting Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: brentuximab vedotin;   Drug: bendamustine
28 Completed
Has Results
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Childhood Lymphocyte Depletion Hodgkin Lymphoma;   Childhood Lymphocyte Predominant Hodgkin Lymphoma;   Childhood Mixed Cellularity Hodgkin Lymphoma;   Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Childhood Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Drug: ifosfamide;   Drug: bortezomib;   Drug: vinorelbine tartrate;   Biological: filgrastim
29 Completed A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Ifosfamide, Gemcitabine, Vinorelbine;   Drug: Bortezomib + IGEV
30 Active, not recruiting Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
Conditions: Childhood Favorable Prognosis Hodgkin Lymphoma;   Childhood Lymphocyte Depletion Hodgkin Lymphoma;   Childhood Mixed Cellularity Hodgkin Lymphoma;   Childhood Nodular Sclerosis Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma
Interventions: Radiation: radiation therapy;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Drug: prednisone;   Drug: cyclophosphamide;   Drug: ifosfamide;   Drug: vinorelbine tartrate;   Drug: dexamethasone;   Drug: etoposide phosphate;   Drug: cisplatin;   Drug: cytarabine;   Biological: filgrastim
31 Recruiting Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
Conditions: Stage II Childhood Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Drug: brentuximab vedotin;   Drug: etoposide;   Drug: prednisone;   Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: Dacarbazine(R);   Drug: filgrastim;   Procedure: quality of life assessment;   Radiation: radiation therapy
32 Active, not recruiting Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
Conditions: Childhood Lymphocyte Predominant Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Procedure: conventional surgery;   Drug: cyclophosphamide;   Drug: prednisone;   Drug: vincristine sulfate;   Radiation: radiation therapy
33 Recruiting Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic
Condition: Hodgkin's Disease
Intervention: Other: Collection of blood specimen
34 Active, not recruiting Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide
35 Completed
Has Results
Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma
Conditions: Adult Favorable Prognosis Hodgkin Lymphoma;   Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Adult Unfavorable Prognosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: vorinostat;   Other: laboratory biomarker analysis
36 Unknown  Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin's Disease
Intervention: Drug: I-131 Tositumomab therapeutic regimen
37 Recruiting Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A
Condition: Hodgkin Disease
Interventions: Drug: ABVE-PC;   Drug: DECA
38 Completed Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma
Condition: Hodgkin's Disease
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: Doxorubicin (Adriamycin);   Drug: Gemcitabine
39 Recruiting Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Conditions: Lymphoma, Non-Hodgkin;   Hodgkin's Disease
Intervention:
40 Recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Drug: dacarbazine;   Procedure: quality-of-life assessment;   Genetic: DNA analysis;   Genetic: RNA analysis;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Genetic: polymorphism analysis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years